B-type natriuretic peptide (BNP) attenuates the L-type calcium current and regulates ventricular myocyte function

Regulatory Peptides

Volumn 151, Issue 1-3, 2008, Pages 95-105

  Sodi, R ^a,b   Dubuis, E ^b   Shenkin, A ^a,b   Hart, G ^b  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Action potential; B type natriuretic peptide; Calcium current; Calcium transients; Ventricular myocytes

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL L TYPE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL FUNCTION; CELL SIZE; CHANNEL GATING; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART VENTRICLE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CALCIUM CHANNELS, L-TYPE; ELECTROPHYSIOLOGY; MALE; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

RATTUS;

EID: 56249102049     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.06.006     Document Type: Article

References (46)

1. 2+ channel inactivation in controlling heart excitation. Proc Natl Acad Sci USA 99 (2002) 17185-17190
2. Baxter G. The natriuretic peptides. Basic Res Cardiol 99 (2004) 71-75
3. Boyett M.R., Moore M., Jewell B.R., Montgomery R.A.P., Kirby M.S., and Orchard C.H. An improved apparatus for the optical recording of contraction of single heart cells. Pflugers Arch 413 (1988) 197-205
4. 2+ currents in cardiac myocytes: old story, new insights. Prog Biophys Mol Biol 91 (2006) 1-82
5. 2+ concentration and rate adaptation of the cardiac action potential. Cell Calcium 35 (2004) 557-573
6. 2+ channels. Prog Biophys Mol Biol 90 (2006) 104-117
7. Clerico A., and Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50 (2004) 33-50
8. Doust J.A., Pietrzak E., Dobson A., and Gasziou P.P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. Brit Med J 330 (2005) 625-634
9. D'Souza S.P., Davis M., and Baxter G.F. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 101 (2004) 113-129
10. Fowkes R.C., and McArdle C.A. C-type natriuretic peptide: an important neuroendocrine regulator?. Trends Endocrinol Metab 11 (2000) 333-338
11. 2+] during inotropic interventions in isolated rat myocytes. J Physiol 437 (1991) 351-375
12. Gisbert M.P., and Fischmeister R. Atrial natriuretic factor regulates the calcium current in frog isolated cardiac cells. Circ Res 62 (1988) 660-667
13. Goetze J.P., Kastrup J., and Rehfeld J.F. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?. Eur Heart J 24 (2003) 1471-1472
14. Hawkridge A.M., Heublein D.M., Bergen H.R., Cataliotti A., Burnett J.C., and Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci USA 102 (2005) 17442-17447
15. Houser S.R., Piacentino V., and Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 32 (2000) 1595-1607
16. 2+ in ventricular myocytes from the streptozotocin-induced diabetic rat. Ann NY Acad Sci 1084 (2006) 155-165
17. Isenberg G., and Klockner U. Calcium currents of isolated bovine ventricular myocytes are fast and of large amplitude. Pflugers Arch 395 (1982) 30-41
18. v3.1, by sibutramine. J Pharmacol Exp Ther 321 (2007) 753-762
19. 2+ ATPase expression. Circulation 113 (2006) 2724-2732
20. Kuhn M. Structure, regulation and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93 (2003) 700-709
21. Lam C.S.P., Burnett J.C., Costello-Boerrigter L., Rodeheffer R.J., and Redfield M.M. Alternate circulating Pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 49 (2007) 1193-1202
22. Lebeche D., Kaprielian R., and Hajjar R. Modulation of action potential duration on myocyte hypertrophic pathways. J Mol Cell Cardiol 40 (2006) 725-735
23. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
24. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
25. Liang F., O'Rear J., Schellenberger U., Tai L., Lasecki M., Schreiner G.F., et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 49 (2007) 1071-1078
26. Luchner A., Stevens T.L., Borgeson D.D., Redfield M., Wei C.M., Porter G., et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol Heart Circ Physiol 274 (1998) H1684-H1689
27. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
28. McGrath M.F., de Bold M.L.K., and de Bold A.J. The endocrine function of the heart. Trends Endocrinol Metab 16 (2005) 469-477
29. Meyer M., Schillinger W., Pieske B., Holubarsch C., and Heilman G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92 (1995) 778-784
30. Mukoyama M., Nakao K., Hosoda K., Suga S.I., Saito Y., Ogawa Y., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 87 (1991) 1402-1412
31. 2 Ach receptor. Am J Physiol 281 (2001) C1251-C1258
32. Nir A., Zhang D.F., Fixler R., Burnett J.C., Eilam Y., and Hasin Y. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes. Eur J Pharmacol 412 (2001) 195-201
33. Ohkusa T., Noma T., Ueyama T., Hisamatsu Y., Yano M., Esato K., et al. Differences in sarcoplasmic reticulum gene expression in myocardium from patients undergoing cardiac surgery. Quantification of steady state levels of messenger RNA using reverse transcription-polymerase chain reaction. Heart Vessels 12 (1997) 1-9
34. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signalling functions. Endocr Rev 27 (2006) 47-72
35. Rae J.L., Cooper K., Gates P., and Watsky M. Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37 (1991) 15-26
36. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
37. Sackner-Bernstein J.D., Kowalski M., Fox M., and Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomised controlled trials. JAMA 293 (2005) 1900-1905
38. Sawada Y., Suda M., Yokoyama H., et al. Stretch-induced hypertrophic growth of cardiomyocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin. J Biol Chem 272 (1997) 20545-20554
39. Strain W.D. The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure. J Clin Prac 11 (2004) 1081-1087
40. Sumida E., Nohara M., Muro A., Sumida E., Kaku H., Koga Y., et al. Altered calcium handling in compensated hypertrophied rat cardiomyocytes induced by pressure overload. Jpn Circ J 62 (1998) 36-46
41. 2+ current in rat ventricular myocytes. Circ Res 77 (1995) 803-812
42. Topol E. Nesiritide - not verified. N Engl J Med 353 (2005) 113-116
43. Walker J.M. The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol 32 (1994) 5-8
44. White R.E., Lee A.B., Shcherbatko A.D., Lincoln T.M., Schonbrunn A., and Armstrong D.L. Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature 361 (1993) 263-266
45. Wollert K.C., Yurukova S., Kilic A., Begrow F., Fiedler B., Gambaryan S., et al. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I. Br J Pharmacol 140 (2004) 1227-1236
46. Zhang Q., Moalem J., Tse J., Scholz P.M., and Weiss H.R. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signalling. Eur J Pharmacol 510 (2005) 209-215